WATSON PHARMACEUTICALS INC·4

Dec 17, 4:09 PM ET

FEDIDA MICHAEL J 4

4 · WATSON PHARMACEUTICALS INC · Filed Dec 17, 2010

Insider Transaction Report

Form 4
Period: 2010-12-15
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0033

    2010-12-16$26.60/sh+10,000$266,00026,441 total
  • Sale

    Common Stock, par value $0.0033

    2010-12-15$51.07/sh2,043$104,34019,625 total
  • Sale

    Common Stock, par value $0.0033

    2010-12-15$51.07/sh100$5,10716,825 total
  • Sale

    Common Stock, par value $0.0033

    2010-12-15$51.08/sh384$19,61516,441 total
  • Sale

    Common Stock, par value $0.0033

    2010-12-15$51.07/sh2,700$137,89216,925 total
  • Exercise/Conversion

    Non-Qualified Options to Purchase Common Stock

    2010-12-1610,00020,000 total
    Exercise: $26.60From: 2003-05-20Exp: 2012-05-20Common Stock, par value $0.0033 (10,000 underlying)
Footnotes (1)
  • [F1]Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -